What is Assembly Biosciences's net investment in lease?

Assembly Biosciences (ASMB) reported net investment in lease of $2.37M in Q1 2026.

How has Assembly Biosciences's net investment in lease changed year-over-year?

Assembly Biosciences's net investment in lease decreased by 19.1% year-over-year, from $2.93M to $2.37M.

What is the long-term trend for Assembly Biosciences's net investment in lease?

Over 5 years (2020 to 2025), Assembly Biosciences's net investment in lease has grown at a -22.8% compound annual growth rate (CAGR), from $9.13M to $2.51M.

Assembly Biosciences ASMB Net Investment in Lease

Net Investment in Lease at other companies

Arrowhead ResearchARWR

——

ALN

Alnylam PharmaceuticalsALNY

——

Avalo TherapeuticsAVTX

——

Vir Biotechnology, Inc.VIR

——

Absci CorporationABSI

——

AbCellera Biologics Inc.ABCL

——

Other financials

Income statement

See full

Revenue$8.2M-12.8%

Operating income-$11.4M-14.4%

Net income-$9.1M-3.0%

EPS (diluted)-$0.54+53.8%

Balance sheet

See full

Cash & equivalents$31.1M+32.9%

Total debt$2.5M-17.5%

Total equity$198.6M+632%

Total assets$235.5M+138%

Cash flow

See full

Operating cash flow-$22.1M+5.7%

CapEx$19.0K—

Free cash flow-$22.1M+5.6%

Valuation

See full

Market cap$480.77M+262%

Enterprise value$452.14M+302%

P/S6.8×+2.6×

Profitability

See full

Operating margin-116.8%-26.1pp

Net margin-103.6%-22.7pp

FCF margin-150%-231pp

Returns & leverage

See full

Return on equity-36.9%-15.1pp

Debt / equity0×-0.1×

Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Assembly Biosciences's net investment in lease?: Assembly Biosciences (ASMB) reported net investment in lease of $2.37M in Q1 2026.
How has Assembly Biosciences's net investment in lease changed year-over-year?: Assembly Biosciences's net investment in lease decreased by 19.1% year-over-year, from $2.93M to $2.37M.
What is the long-term trend for Assembly Biosciences's net investment in lease?: Over 5 years (2020 to 2025), Assembly Biosciences's net investment in lease has grown at a -22.8% compound annual growth rate (CAGR), from $9.13M to $2.51M.